TLP Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-256
Closed -$25K 243
2018
Q3
$25K Sell
256
-1,112
-81% -$103K 0.04% 278
2018
Q2
$117K Buy
1,368
+1,032
+307% +$86.2K 0.18% 76
2018
Q1
$27K Sell
336
-4,510
-93% -$372K 0.02% 348
2017
Q4
$391K Buy
4,846
+1,171
+32% +$93.8K 0.27% 35
2017
Q3
$286K Buy
+3,675
New +$305K 0.18% 92
2017
Q2
Sell
-4,654
Closed -$375K 400
2017
Q1
$375K Buy
4,654
+2,020
+77% +$158K 0.26% 136
2016
Q4
$188K Buy
2,634
+1,195
+83% +$93.9K 0.19% 86
2016
Q3
$124K Buy
+1,439
New +$125K 0.13% 183
2016
Q2
Sell
-8,300
Closed -$623K 378
2016
Q1
$623K Buy
8,300
+4,272
+106% +$322K 0.38% 83
2015
Q4
$310K Buy
+4,028
New +$303K 0.25% 116

Other funds holding MDT

TLP Group's MDT Position: Q4 2018 in Review

TLP Group sold out of Medtronic (MDT) in Q4 2018, closing a stake of 256 shares — an estimated $25K sold.

TLP Group first reported a position in MDT in Q4 2015 and held it in 10 quarters. The position peaked at $623K in Q1 2016. 1,563 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

  • TLP Group reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 256 Medtronic shares in Q4 2018, an estimated $25K.
  • TLP Group first reported a position in Medtronic in Q4 2015 and held it in 10 quarters.
  • TLP Group's Medtronic position peaked at $623K in Q1 2016.
  • 1,563 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.